Net Income

After a record 2025 but a mixed Q4, the aerospace supplier's upcoming earnings will reveal its resilience against renewed supply chain disruptions.

With final funding secured, Microporous is set to begin construction on a massive Virginia plant, a key step in strengthening America's EV supply chain.

A new system from OSHIMA goes beyond simple defect detection, integrating AI inspection with spreading and cutting for a seamless smart factory workflow.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

Facing a steep revenue drop, High Arctic banks on a new contract, diversification into rentals and fire services, and the promise of PNG's massive LNG project.

Pair Team's AI 'Flora' joins a new Medicare program to tackle chronic illness by addressing social needs, a bold move in value-based care.

A new analysis claims the RGGI carbon market is backfiring, increasing CO2 and costing consumers billions, sparking a fierce debate over its effectiveness.

ProPetro posts a Q1 loss due to weather but reveals a massive power generation expansion with Caterpillar, betting big on data centers and microgrids.

The energy services giant posts strong Q1 results, capitalizing on a strategic industry shift to offshore projects for enhanced energy security and profits.

Mineral driller Foraco posts 20% revenue growth in Q1, but aggressive expansion and new contract costs take a heavy toll on short-term profits and margins.

With a 90% strike authorization, 10,000 nurses at Corewell Health East demand better staffing and wages, raising concerns for patient care.

OG&E will power three new Google data centers under a novel contract that makes the tech giant pay for grid costs, a model aimed at protecting consumers.

ACRES Commercial Realty posts a Q1 net loss but adds nearly $500M in loans and closes a $1B securitization, signaling a bold strategy amid market headwinds.

Arkay Beverages plans a global network of zero-proof bars, banking on a unique molecule and a $1.5B NASDAQ goal. But can it deliver a true alternative?

France's top insurer posts record-breaking income driven by digital innovation, but profits are eroded by the immense financial toll of severe European storms.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

The French spirits giant posts flat organic growth as currency headwinds and regional challenges obscure a strong Q4 Cognac recovery and liqueur sales.

Aker Solutions posts solid Q1 results with a massive order intake, rewarding shareholders while strategically pivoting towards emerging markets like nuclear energy.

Arcadis reports robust Q1 order intake and improved margins, leaning on its new AI Studio and strategic streamlining to navigate a complex global market.

With a 104B-parameter AI and soaring revenue, Diagens is industrializing diagnostics. Can its ambitious 'Model-as-a-Service' clear global regulatory barriers?